Cargando…

Corrigendum: Identification of Hypoxia Induced Metabolism Associated Genes in Pulmonary Hypertension

Detalles Bibliográficos
Autores principales:	He, Yang-Yang, Xie, Xin-Mei, Zhang, Hong-Da, Ye, Jue, Gencer, Selin, van der Vorst, Emiel P. C., Döring, Yvonne, Weber, Christian, Pang, Xiao-Bin, Jing, Zhi-Cheng, Yan, Yi, Han, Zhi-Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715015/ https://www.ncbi.nlm.nih.gov/pubmed/34975506 http://dx.doi.org/10.3389/fphar.2021.810178

Ejemplares similares

Identification of Hypoxia Induced Metabolism Associated Genes in Pulmonary Hypertension
por: He, Yang-Yang, et al.
Publicado: (2021)

G-Protein Coupled Receptor Targeting on Myeloid Cells in Atherosclerosis
por: van der Vorst, Emiel P. C., et al.
Publicado: (2019)

Regulatory T Cell-Related Gene Indicators in Pulmonary Hypertension
por: Liu, Yan, et al.
Publicado: (2022)

Inflammatory Chemokines in Atherosclerosis
por: Gencer, Selin, et al.
Publicado: (2021)

Role of G-Protein-Coupled Receptors in Cardiovascular Diseases
por: Gencer, Selin, et al.
Publicado: (2023)

Adipocyte-Specific ACKR3 Regulates Lipid Levels in Adipose Tissue
por: Gencer, Selin, et al.
Publicado: (2021)

MIF and CXCL12 in Cardiovascular Diseases: Functional Differences and Similarities
por: van der Vorst, Emiel P. C., et al.
Publicado: (2015)

Chemokines and their receptors in Atherosclerosis
por: van der Vorst, Emiel P. C., et al.
Publicado: (2015)

Sodium Tanshinone II Sulfonate A Ameliorates Hypoxia-Induced Pulmonary Hypertension
por: Bao, Ya-Ru, et al.
Publicado: (2020)

Gouty Offense in Patients With Obstructive Coronary Artery Disease Despite State‐of‐the‐Art Therapy
por: Döring, Yvonne, et al.
Publicado: (2018)

Adipocyte calcium sensing receptor is not involved in visceral adipose tissue inflammation or atherosclerosis development in hyperlipidemic Apoe(−/−) mice
por: Sundararaman, Sai Sahana, et al.
Publicado: (2021)

Hypoxia inducible factor signaling and experimental persistent pulmonary hypertension of the newborn
por: Wedgwood, Stephen, et al.
Publicado: (2015)

Tsantan Sumtang Restored Right Ventricular Function in Chronic Hypoxia-Induced Pulmonary Hypertension Rats
por: Yang, Zhanting, et al.
Publicado: (2021)

Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model
por: Morales-Cano, Daniel, et al.
Publicado: (2023)

Endothelial ACKR3 drives atherosclerosis by promoting immune cell adhesion to vascular endothelium
por: Gencer, Selin, et al.
Publicado: (2022)

PCSK9: A Multi-Faceted Protein That Is Involved in Cardiovascular Biology
por: Sundararaman, Sai Sahana, et al.
Publicado: (2021)

Pipersentan: A De Novo Synthetic Endothelin Receptor Antagonist that Inhibits Monocrotaline- and Hypoxia-Induced Pulmonary Hypertension
por: Zhang, Zeyu, et al.
Publicado: (2022)

Acute Iloprost Inhalation Improves Right Ventricle Function in Pulmonary Artery Hypertension: A Cardiac Magnetic Resonance Study
por: Li, Jing-Hui, et al.
Publicado: (2019)

Corrigendum: Therapeutic potential of topical administration of acriflavine against hypoxia-inducible factors for corneal fibrosis
por: Zhu, Shuyan, et al.
Publicado: (2023)

Corrigendum: Efficacy and safety of riociguat replacing PDE-5is for patients with pulmonary arterial hypertension: A systematic review and meta-analysis
por: Liu, Yu-Yang, et al.
Publicado: (2023)

Protective Effects of 18β-Glycyrrhetinic Acid on Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
por: Zhang, Min, et al.
Publicado: (2019)

Human Mesenchymal Stem Cell Therapy Reverses Su5416/Hypoxia-Induced Pulmonary Arterial Hypertension in Mice
por: Alencar, Allan K. N., et al.
Publicado: (2018)

Using extracellular matrix derived from sugen-chronic hypoxia lung tissue to study pulmonary arterial hypertension
por: Link, Patrick A., et al.
Publicado: (2023)

Implication of proliferation gene biomarkers in pulmonary hypertension
por: Yan, Yi, et al.
Publicado: (2021)

Corrigendum: The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-Word Prospective Study
por: Chen, Yusi, et al.
Publicado: (2022)

Advances in the research of sulfur dioxide and pulmonary hypertension
por: Liu, Xin, et al.
Publicado: (2023)

Magnolol Attenuates Right Ventricular Hypertrophy and Fibrosis in Hypoxia-Induced Pulmonary Arterial Hypertensive Rats Through Inhibition of the JAK2/STAT3 Signaling Pathway
por: Fu, Minyi, et al.
Publicado: (2021)

Traditional Herbal Medicine Discovery for the Treatment and Prevention of Pulmonary Arterial Hypertension
por: Xue, Zhifeng, et al.
Publicado: (2021)

Epigenetic Regulation and Its Therapeutic Potential in Pulmonary Hypertension
por: Wang, Yu, et al.
Publicado: (2018)

Cefminox, a Dual Agonist of Prostacyclin Receptor and Peroxisome Proliferator-Activated Receptor-Gamma Identified by Virtual Screening, Has Therapeutic Efficacy against Hypoxia-Induced Pulmonary Hypertension in Rats
por: Xia, Jingwen, et al.
Publicado: (2018)

Corrigendum: Inflammatory Stress Potentiates Emodin-Induced Liver Injury in Rats
por: Tu, Can, et al.
Publicado: (2021)

Corrigendum: Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review
por: Yang, Zhi-Hua, et al.
Publicado: (2021)

Corrigendum: Tengdan Capsule Prevents Hypertensive Kidney Damage in SHR by Inhibiting Periostin-Mediated Renal Fibrosis
por: Du, Xiaoli, et al.
Publicado: (2022)

Corrigendum: Uncovering the pharmacology of Ginkgo biloba folium in the cell-type-specific targets of Parkinson’s disease with a deep learning algorithm
por: Yan, Yu-Chen, et al.
Publicado: (2023)

Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model
por: Morales-Cano, Daniel, et al.
Publicado: (2023)

Therapeutic Strategies in Pulmonary Hypertension
por: Fuso, Leonello, et al.
Publicado: (2011)

Role of heparanase in pulmonary hypertension
por: Wang, Lin-Jun, et al.
Publicado: (2023)

Editorial: Drug Development and Target Discovery in Pulmonary Vascular Diseases
por: Zhang, Rui, et al.
Publicado: (2020)

Dan-Shen-Yin Granules Prevent Hypoxia-Induced Pulmonary Hypertension via STAT3/HIF-1α/VEGF and FAK/AKT Signaling Pathways
por: Wang, Ran-Ran, et al.
Publicado: (2022)

Corrigendum: Scopoletin Suppresses Activation of Dendritic Cells and Pathogenesis of Experimental Autoimmune Encephalomyelitis by Inhibiting NF-κB Signaling
por: Zhang, Fei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ej481m3hbtmnrsvjr3olmb88m4